• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Atara Biotherapeutics

Conceptual illustration of layoffs featuring rows of translucent human figures overlaid with large blue scissors symbolizing
Favicon Fierce Biotech

Biopharma layoffs hit 4-year monthly high in May

Despite May’s high number, the overall number of layoff rounds reported in the second quarter was exactly the same as in 2025’s Q1.
Gabrielle Masson Jul 8, 2025 2:26pm
Photo of a chain being held together by a piece of rope

Atara hit with cell therapy clinical hold after FDA inspection

Jan 21, 2025 9:59am
FDA

Atara, Pierre Fabre hit a hurdle with Ebvallo in the US

Jan 16, 2025 9:36am
Pierre Fabre

Pierre Fabre commits up to $640M in T-cell deal with Atara

Nov 3, 2023 11:04am
immune diseases

Off-the-shelf T-cell therapy wins world-first approval

Dec 19, 2022 3:22pm
Vaccine business

'The Top Line': Pfizer's kickback lawsuit, top vaccine companies

Oct 21, 2022 6:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings